Literature DB >> 2463918

Increased neurotransmitter biosynthesis in phenylketonuria induced by phenylalanine restriction or by supplementation of unrestricted diet with large amounts of tyrosine.

C Lykkelund1, J B Nielsen, H C Lou, V Rasmussen, A M Gerdes, E Christensen, F Güttler.   

Abstract

Seven phenylketonuria (PKU) patients aged 15-24 years were allowed unrestricted diet for 3 weeks. Three of these patients performed well on unrestricted diet according to visual reaction time variability (RTv 50-100 ms) and did not show significant changes when returning to the phenylalanine-restricted diet (RTv 70-100 ms). Neither did the concentrations of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF) change significantly. Four of the patients, however, performed rather poorly (RTv 120-220 ms) on unrestricted diet and improved significantly (P less than 0.03) when the diet was restored (RTv 70-150 ms). The improvements were accompanied by significant (P less than 0.01 and P less than 0.02) increases (mean 52% and 109%) in CSF levels of HVA and 5-HIAA. Five PKU patients aged 15-23 years were allowed unrestricted diet or unrestricted diet supplemented with various amounts of tyrosine (106-194 mg/kg per 24 h). Two of these patients performed very well on unrestricted diet (RTv 60 ms) and showed little change when the unrestricted diet was supplemented with tyrosine (RTv 70 ms and 80 ms). The three other patients, who performed rather poorly (RTv 120-220 ms), improved significantly (P less than 0.03) when the unrestricted diet was supplemented with tyrosine (RTv 70-140 ms). HVA in CSF increased significantly (P less than 0.01) with the tyrosine supplement when the amount exceeded a threshold of approximately 80 mg/kg per 24 h.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2463918     DOI: 10.1007/bf00441411

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  40 in total

1.  Protein synthesis in liver, muscle, and brain of rats fed a high tyrosine-low protein diet.

Authors:  C Ip; A E Harper
Journal:  J Nutr       Date:  1975-07       Impact factor: 4.798

2.  Local and systemic effects of phenylalanine on intestinal transport of tyrosine and tryptophan.

Authors:  R A Wapnir; R L Hawkins; F Lifshitz
Journal:  Proc Soc Exp Biol Med       Date:  1972-06

3.  Tryptophan hydroxylation in mammalian systems.

Authors:  W Lovenberg; E Jequier; A Sjoerdsma
Journal:  Adv Pharmacol       Date:  1968

4.  Glutamine in the phenylketonuric central nervous system.

Authors:  C M McKean; N A Peterson
Journal:  N Engl J Med       Date:  1970-12-17       Impact factor: 91.245

5.  Evidence for separate systems for the transport of neutral and basic amino acids across the blood-brain barrier.

Authors:  J J Richter; A Wainer
Journal:  J Neurochem       Date:  1971-04       Impact factor: 5.372

Review 6.  Diet termination in children with phenylketonuria: a review of psychological assessments used to determine outcome.

Authors:  S E Waisbren; R R Schnell; H L Levy
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

7.  The effects of tryptophan and tyrosine on human mood and performance.

Authors:  H R Lieberman; S Corkin; B J Spring; G S Garfield; J H Growdon; R J Wurtman
Journal:  Psychopharmacol Bull       Date:  1984

8.  Influence of high concentrations of phenylalanine on the amino acids of cerebrospinal fluid and blood.

Authors:  C M McKean; D E Boggs
Journal:  Proc Soc Exp Biol Med       Date:  1966 Aug-Sep

9.  Inhibition by L-phenylalanine of tyrosine transport by synaptosomal plasma membrane vesicles: implications in the pathogenesis of phenylketonuria.

Authors:  M C Aragón; C Giménez; F Valdivieso
Journal:  J Neurochem       Date:  1982-10       Impact factor: 5.372

10.  Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man.

Authors:  W Krause; M Halminski; L McDonald; P Dembure; R Salvo; D Freides; L Elsas
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

View more
  19 in total

1.  Metabolomic changes demonstrate reduced bioavailability of tyrosine and altered metabolism of tryptophan via the kynurenine pathway with ingestion of medical foods in phenylketonuria.

Authors:  Denise M Ney; Sangita G Murali; Bridget M Stroup; Nivedita Nair; Emily A Sawin; Fran Rohr; Harvey L Levy
Journal:  Mol Genet Metab       Date:  2017-04-06       Impact factor: 4.797

2.  The control of 5-hydroxytryptamine and dopamine synthesis in the brain: a theoretical approach.

Authors:  F A Hommes; J S Lee
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.

Authors:  Emily A Sawin; Sangita G Murali; Denise M Ney
Journal:  Mol Genet Metab       Date:  2014-02-08       Impact factor: 4.797

4.  Tetrahydrobiopterin treatment reduces brain L-Phe but only partially improves serotonin in hyperphenylalaninemic ENU1/2 mice.

Authors:  Tanja Scherer; Gabriella Allegri; Christineh N Sarkissian; Ming Ying; Hiu Man Grisch-Chan; Anahita Rassi; Shelley R Winn; Cary O Harding; Aurora Martinez; Beat Thöny
Journal:  J Inherit Metab Dis       Date:  2018-03-08       Impact factor: 4.982

5.  Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU).

Authors:  Cary O Harding; Shelley R Winn; K Michael Gibson; Erland Arning; Teodoro Bottiglieri; Markus Grompe
Journal:  J Inherit Metab Dis       Date:  2014-02-03       Impact factor: 4.982

Review 6.  New frontiers in neuroimaging applications to inborn errors of metabolism.

Authors:  Morgan J Prust; Andrea L Gropman; Natalie Hauser
Journal:  Mol Genet Metab       Date:  2011-06-30       Impact factor: 4.797

Review 7.  Large neutral amino acids in the treatment of PKU: from theory to practice.

Authors:  Francjan J van Spronsen; Martijn J de Groot; Marieke Hoeksma; Dirk-Jan Reijngoud; Margreet van Rijn
Journal:  J Inherit Metab Dis       Date:  2010-10-26       Impact factor: 4.982

Review 8.  Tyrosine supplementation for phenylketonuria.

Authors:  Diana Webster; Joanne Wildgoose
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

9.  Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice.

Authors:  Shelley R Winn; Tanja Scherer; Beat Thöny; Ming Ying; Aurora Martinez; Sydney Weber; Jacob Raber; Cary O Harding
Journal:  Mol Genet Metab       Date:  2017-10-19       Impact factor: 4.797

10.  A preliminary report on dopamine system reactivity in PKU: acute effects of haloperidol on neuropsychological, physiological, and neuroendocrine functions.

Authors:  Monica Luciana; Karen L Hanson; Chester B Whitley
Journal:  Psychopharmacology (Berl)       Date:  2004-03-13       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.